Home > What's New > Join Crittenton in Cancer Prevention Study

Join Crittenton in Cancer Prevention Study

American Cancer SocietyCancer is a word heard too often both here at Crittenton Hospital Medical Center and in our community. That is why we are fighting back against this disease with our long-time partner – the American Cancer Society – by encouraging you to consider taking part in the Cancer Prevention Study-3 (CPS-3). One hundred years ago, the Society began the fight of a lifetime – the fight to end cancer. CPS-3 will get us closer to finishing the fight.

The ultimate goal of CPS-3 is to enroll men and women from various racial/ethnic backgrounds from across the U.S. to participate in a study that will help researchers better understand the lifestyle, environmental and genetic factors that cause or prevent cancer and will save lives.

If you are between the ages of 30 and 65 years old and have never been diagnosed with cancer, you are eligible to enroll. Enrollment will be available on November 7, 2013 from 10:00am-1:30pm in the North Addition Conference Rooms – 2C & 2D.

In order to schedule your appointment, please visit: cancer.org/semicps3

Participating is easy and involves the following:

  • Read and sign an informed consent form.
  • Complete a survey packet which will ask for detailed information on lifestyle, behavioral, and other factors related to your health.
  • Be measured for waist circumference.
  • Give a small blood sample (similar to a doctor’s visit). The blood sample is drawn by a trained, certified phlebotomist.
  • Completing a mailed survey every few years over the next 20-30 years

All personal information and any individual results of blood analyses that may be performed will be kept strictly confidential by CPS-3 research staff. There will be no cost to you to participate.

For more information about CPS-3, please visit cancer.org/cps3, email cps3@cancer.org or call toll-free 1.888.604.5888.

With your help we can make this cancer’s last century and finish the fight.

Leave a Reply